BRIEF published on 04/05/2024 at 18:05, 7 months 15 days ago CALIDA Holding AG's 2024 Annual General Meeting Concludes Successfully Annual General Meeting Board Members Corporate Governance Dividend Calida Holding AG
PRESS RELEASE published on 04/05/2024 at 18:00, 7 months 15 days ago CALIDA Holding AG 2024 Annual General Meeting – all proposals approved CALIDA Holding AG shareholders approve all proposals at 2024 Annual General Meeting, including re-election of Board members and dividend distribution Shareholders Board Members Dividend Distribution Calida Holding AG 2024 Annual General Meeting
BRIEF published on 02/23/2024 at 07:00, 8 months 27 days ago 2023 Annual Report of CALIDA GROUP: Facing Challenges and Strategic Direction Revenue Dividends Online Commerce CALIDA GROUP Strategic Reorientation
BRIEF published on 02/23/2024 at 07:00, 8 months 27 days ago 2023 Annual Results of CALIDA Holding AG: Strong Operational Performance During a Period of Strategic Realignment Business Strategy Dividend Online Sales 2023 Financial Results Calida Holding AG
PRESS RELEASE published on 02/23/2024 at 07:00, 8 months 27 days ago CALIDA Holding AG: Annual financial statements 2023 CALIDA Holding AG reports solid operational performance and strategic realignment in their 2023 annual financial statements. Sales slightly lower at CHF 304.4 million, with profitable core brands driving growth Annual Financial Statements Operational Performance Calida Holding AG Strategic Realignment Core Brands
PRESS RELEASE published on 09/12/2023 at 07:00, 1 year 2 months ago CALIDA Holding AG: Operational excellence as new strategic focus – EBIT margin of 10% as target by 2026 – focus online business on Group brands – impairment at COSABELLA
PRESS RELEASE published on 07/27/2023 at 07:00, 1 year 3 months ago CALIDA Holding AG: Half-year results 2023
PRESS RELEASE published on 06/15/2023 at 07:00, 1 year 5 months ago CALIDA GROUP expects slightly lower sales – divestment of ERLICH TEXTIL – Felix Sulzberger to become executive Chairman of the Board
PRESS RELEASE published on 05/11/2023 at 07:01, 1 year 6 months ago CALIDA Holding AG: CALIDA GROUP appoints Dave Müller as Chief Financial Officer
PRESS RELEASE published on 04/19/2023 at 18:00, 1 year 7 months ago CALIDA Holding AG 2023 Annual General Meeting – all proposals approved
Published on 11/21/2024 at 10:03, 48 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 51 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 51 minutes ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 16 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 26 minutes ago Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 10:30, 21 minutes ago MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 46 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 49 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 51 minutes ago Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 51 minutes ago Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 06:58, 3 hours 53 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 31 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 6 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 6 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
